Adjuvant Tamoxifen Influences the Lipid Profile in Breast Cancer Patients

作者：Lin Che; Chen Li Sheng; Kuo Shou Jen; Chen Dar Ren^*

来源：Breast Care, 2014, 9(1): 35-39.

DOI：10.1159/000358752

• Breast cancer
• Tamoxifen
• Metabolism
• Lipid profile
• Total cholesterol
• Low-density lipoprotein cholesterol

Background: Currently there is a debate regarding whether tamoxifen used in breast cancer has an impact on lipid profiles. The aim of this study was to determine whether tannoxifen has an impact on the serum lipid profile in Taiwanese women. Patients and Methods: Data of 109 patients were collected from the routine clinical follow-up for women with hormone receptorpositive breast cancer who were treated between July 2005 and March 2008. These patients were divided into 2 subgroups, based on their tumor grade and lymph node status. Subgroup 1 patients had tumor grade I/II and a negative lymph node status. Those patients with tumor grade III or a positive lymph node status were defined as subgroup 2. Results: In the 109 patients, the mean serum total cholesterol (TC) levels after tamoxifen treatment, as well as the serum low-density lipoprotein cholesterol (LDL-C) levels, were lower than the baseline levels, with statistically significant differences. Treatment with tamoxifen lowered the serum TC and LDL-C levels in both subgroups. Conclusions: The results indicate that tamoxifen has an impact on the serum lipid profile of breast cancer patients in Taiwan. Physicians should follow up the lipid profile in these patients.

• 出版日期2014